212
Views
14
CrossRef citations to date
0
Altmetric
Review

Hypertension in adolescents

, &
Pages 1595-1603 | Published online: 10 Jan 2014

References

  • Hajjar I, Kotchen TA. Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988–2000. JAMA290, 199–206 (2003).
  • Whelton PK, Beevers DG, Sonkodi S. Strategies for improvement of awareness, treatment and control of hypertension: results of a panel discussion. J. Hum. Hypertens.18, 563–565 (2004).
  • Chen X, Wang Y. Tracking of blood pressure from childhood to adulthood: a systematic review and meta-regression analysis. Circulation117, 3171–3180 (2008).
  • Ingelfinger JR. Pediatric antecedents of adult cardiovascular disease - awareness and intervention. N. Engl. J. Med.350, 2123–2126 (2004).
  • Muntner P, He J, Cutler JA, Wildman RP, Whelton PK. Trends in blood pressure among children and adolescents. JAMA291, 2107–2113 (2004).
  • Beilin L, Huang RC. Childhood obesity, hypertension, the metabolic syndrome and adult cardiovascular disease. Clin. Exp. Pharmacol. Physiol.35, 409–411 (2008).
  • Warren WR. An overview of pediatric obesity. Pediatric Diabetes8, 76–87 (2007).
  • Flynn JT. Pediatric hypertension: recent trends and accomplishments, future challenges. Am. J. Hypertens.21, 605–612 (2008).
  • National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents. The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics114, 555–576 (2004).
  • Hansen TW, Staessen JA, Zhang H et al. Cardiovascular outcome in relation to progression to hypertension in the Copenhagen MONICA cohort. Am. J. Hypertens.20, 483–491 (2007).
  • Hansen ML, Gunn PW, Kaelber DC. Underdiagnosis of hypertension in children and adolescents. JAMA298, 874–879 (2007).
  • Falkner B, Gidding SS, Portman R, Rosner B. Blood pressure variability and classification of prehypertension and hypertension in adolescence. Pediatrics122, 238–242 (2008).
  • Kaelber DC, Pickett F. Simple table to identify children and adolescents needing further evaluation of blood pressure. Pediatrics123, e972–e974 (2009).
  • Falkner B, Sadowski RH. Hypertension in children and adolescents. Am. J. Hypertens.8, S106–S110 (1995).
  • Flynn JT. Hypertension in adolescents. Adolesc. Med.16, 11–29 (2005).
  • Hamet P, Pausova Z, Adarichev V, Adaricheva K, Tremblay J. Hypertension: genes and environment. J. Hypertens.16, 397–418 (1998).
  • Kupper N, Ge D, Treiber FA, Snieder H. Emergence of novel genetic effects on blood pressure and hemodynamics in adolescence: the Georgia Cardiovascular Twin Study. Hypertension47, 948–954 (2006).
  • Garin EH, Araya CE. Treatment of systemic hypertension in children and adolescents. Curr. Opin. Pediatr.21, (2009) (Epub ahead of print).
  • Grinsell MM, Norwood VF. At the bottom of the differential diagnosis list: unusual causes of pediatric hypertension. Pediatr. Nephrol. (2008) (Epub ahead of print).
  • Aglony M, Arnaiz P, Acevedo M et al. Blood pressure and family history of hypertension in children from Santiago, Chile. Rev. Med. Chile137, 39–45 (2009).
  • Rotteveel J, van Weissenbruch MM, Twisk JW, Delemarre-Van de Waal HA. Infant and childhood growth patterns, insulin sensitivity, and blood pressure in prematurely born young adults. Pediatrics122, 313–321 (2008).
  • Ford ES, Mokdad AH, Ajani UA. Trends in risk factors for cardiovascular disease among children and adolescents in the United States. Pediatrics4, 1534–1544 (2004).
  • McGavock JM, Torrance B, McGuire KA, Wozny P, Lewanczuk RZ. The relationship between weight gain and blood pressure in children and adolescents. Am. J. Hypertens.20, 1038–1044 (2007).
  • Baker JL, Olsen LW, Sørensen TI. Childhood body-mass index and the risk of coronary heart disease in adulthood. N. Engl. J. Med.357, 2329–2337 (2007).
  • Daniels SR. Is there an epidemic of cardiovascular disease on the horizon? J. Pediatr.134, 665–666 (1999).
  • Koulouridis E, Georgalidis K, Kostimpa I. Factors influencing blood pressure control in children and adolescents. Int. Urol. Nephrol.40, 741–748 (2008).
  • Baba R, Koketsu M, Nagashima M, Inasaka H, Yoshinaga M, Yokota M. Adolescent obesity adversely affects blood pressure and resting heart rate. Circ. J.71, 722–726 (2007).
  • Knerr I, Dost A, Lepler R et al. Tracking and prediction of arterial blood pressure from childhood to young adulthood in 868 patients with Type 1 diabetes: a multicenter longitudinal survey in Germany and Austria. Diabetes Care31, 726–727 (2008).
  • Croix B, Feig D. Childhood hypertension is not a silent disease. Pediatr. Nephrol.21, 527–532 (2006).
  • Daniels SR. Cardiovascular sequelae of childhood hypertension. Am. J. Hypertens.15, 61S–63S (2002).
  • Stabouli S, Kotsis V, Rizos Z, Toumanidis S, Karagianni C, Constantopoulos A, Zakopoulos N. Left ventricular mass in normotensive, prehypertensive and hypertensive children and adolescents. Pediatr. Nephrol.24, 1545–1551 (2009)
  • Khoury PR, Mitsnefes M, Daniels SR, Kimball TR. Age-specific reference intervals for indexed left ventricular mass in children. J. Am. Soc. Echocardiogr.22, 709–714 (2009).
  • Lauschke J and Maisch B. Athlete’s heart or hypertrophic cardiomyopathy? Clin. Res. Cardiol.98, 80–88 (2008).
  • Brady TM, Fivush B, Flynn JT, Parekh R. Ability of blood pressure to predict left ventricular hypertrophy in children with primary hypertension. J. Pediatr.152, 73–78 (2008).
  • McNiece KL, Gupta-Malhotra M, Samuels J et al. Left ventricular hypertrophy in hypertensive adolescents: analysis of risk by 2004 National High Blood Pressure Education Program Working Group staging criteria. Hypertension50, 392–395 (2007).
  • Lurbe E, Cifkova R, Cruickshank JK et al. Management of high blood pressure in children and adolescents: recommendations of the European Society of Hypertension. J. Hypertens.27, 1719–1742 (2009).
  • Seeman T, Gilík J, Vondrák K, Simková E, Flögelová H, Hladíková M, Janda J. Regression of left-ventricular hypertrophy in children and adolescents with hypertension during ramipril monotherapy. Am. J. Hypertens.20, 990–996 (2007).
  • Litwin M, Niemirska A. Intima-media thickness measurements in children with cardiovascular risk factors. Pediatr. Nephrol.24, 707–719 (2009).
  • Barja S, Acevedo M, Arnaiz P et al. Early markers for atherosclerosis and metabolic syndrome in children. Rev. Med. Chile137, 522–530 (2009).
  • Urbina E, Alpert B, Flynn J et al. Ambulatory blood pressure monitoring in children and adolescents: recommendations for standard assessment: a scientific statement from the American Heart Association Atherosclerosis, Hypertension, and Obesity in Youth Committee of the council on cardiovascular disease in the young and the council for high blood pressure research. Hypertension52, 433–451 (2008).
  • Acosta AA, McNiece KL. Ambulatory blood pressure monitoring: a versatile tool for evaluating and managing hypertension in children. Pediatr. Nephrol.23, 1399–1408 (2008).
  • Graves JW, Althaf MM. Utility of ambulatory blood pressure monitoring in children and adolescents. Pediatr. Nephrol.21, 1640–1652 (2006).
  • Stergiou GS, Alamara CV, Salgami EV, Vaindirlis IN, Dacou-Voutetakis C, Mountokalakis TD. Reproducibility of home and ambulatory blood pressure in children and adolescents. Blood Press. Monit.10, 143–147 (2005).
  • Morgenstern B. Blood pressure, hypertension, and ambulatory blood pressure monitoring in children and adolescents. Am. J. Hypertens.15, S64–S66 (2002).
  • Parati G, Stergiou GS, Asmar R et al. European Society of Hypertension guidelines for blood pressure monitoring at home: a summary report of the Second International Consensus Conference on Home Blood Pressure Monitoring. J. Hypertens.26, 1505–1526 (2008).
  • Lurbe E, Redon J. Discrepancies in office and ambulatory blood pressure in adolescents: help or hindrance? Pediatr. Nephrol.23, 341–345 (2008).
  • Lurbe E, Invitti C, Torro I et al. The impact of the degree of obesity on the discrepancies between office and ambulatory blood pressure values in youth. J. Hypertens.24, 1557–1564 (2006).
  • Lurbe E, Torro I, Aguilar F et al. Added impact of obesity and insulin resistance in nocturnal blood pressure elevation in children and adolescents. Hypertension51, 635–641 (2008).
  • Ruiz M, Garcia V, Glez M, Garcia M, Valenzuela C, Aguirre A. Reduced nocturnal systolic blood pressure dip in obese children. Nefrologia28, 517–524 (2008).
  • Shatat IF, Freeman KD, Vuguin PM, Dimartino-Nardi JR, Flynn JT. Relationship between adiponectin and ambulatory blood pressure in obese adolescents. Pediatr. Res.65, 691–695 (2009).
  • Arnaiz P, Acevedo M, Barja S, Aglony M et al. Adiponectin levels, cardiometabolic risk factors and markers of subclinical atherosclerosis in children. Int. J. Cardiol.5, (2008) (Epub ahead of print).
  • Kavey RW, Kveseus DA, Atallah N, Smith FC. White-coat hypertension in childhood: evidence for end-organ effect. J. Pediatr.150, 491–497 (2007).
  • Lande M, Meagher C, Fisher SG et al. Left ventricular mass index in children with white-coat hypertension. J. Pediatr.153, 50–54 (2008).
  • Matsuoka S, Awazu M. Masked hypertension in children and young adults. Pediatr. Nephrol.19, 651–654 (2004).
  • Lurbe E, Torro I, Alvarez V et al. Prevalence, persistence, and clinical significance of masked hypertension in youth. Hypertension45, 493–498 (2005).
  • Richey PA, Disessa TG, Hastings MC, Somes GW, Alpert BS, Jones DP. Ambulatory blood pressure and increased left ventricular mass in children at risk for hypertension. J. Pediatr.152, 343–348 (2008).
  • Mancia G, Bombelli M, Fachetti R, Madotto F, Quarti-Trevano F, Polo Friz H, Grassi G, Sega R. Long-term risk of sustained hypertension in white-coat or masked hypertension. Hypertension54, 226–232 (2009).
  • Ettinger LM, Freeman K, Dimartino-nardi JR, Flynn JT. Microalbuminuria and abnormal ambulatory blood pressure in adolescents with Type 2 diabetes mellitus. J. Pediatr.147, 67–73 (2005).
  • Darcan S, Goksen D, Mir S et al. Alterations of blood pressure in Type 1 diabetic children and adolescents. Pediatr. Nephrol.21, 672–676 (2006).
  • Chiarelli F, Trotta D, Verrotti A, Mohn A. Treatment of hypertension and microalbuminuria in children and adolescents with Type 1 diabetes mellitus. Pediatr. Diabetes3, 113–124 (2002).
  • Alpay H, Ozdemir N, Wüh E, Topuzoglu A. Ambulatory blood pressure monitoring in healthy children with parental hypertension. Pediatr. Nephrol.24, 155–161 (2009).
  • Lurbe E, Carvajal E, Torro I et al. Influence of concurrent obesity and low birth weight on blood pressure phenotype in youth. Hypertension53, 912–917 (2009).
  • Bayrakci US, Schaefer F, Duzova A, Yigit S, Bakkaloglu A. Abnormal circadian blood pressure regulation in children born preterm. J. Pediatr.151, 399–403 (2007).
  • Menard J. A vaccine for hypertension. J. Hypertens.25, 41–46 (2007).
  • Gradman AH, Pinto R. Vaccination: a novel strategy for inhibiting the renin-angiotensin-aldosterone system. Curr. Hypertens. Rep.10, 473–479 (2008).
  • Miller SA, Accardi JR, St Onge EL. Angiotensin II vaccine: a novel approach in the treatment of hypertension. Expert Opin. Biol. Ther.8, 1669–1673 (2008).
  • Falkner B. Children and adolescents with obesity-associated high blood pressure. J. Am. Soc. Hypertens.2, 267–274 (2008).
  • Ford CA, Nonnemaker JM, Wirth KE. The influence of adolescent body mass index, physical activity, and tobacco use on blood pressure and cholesterol in young adulthood. J. Adolesc. Health43, 576–583 (2008).
  • Torrance B, McGuire KA, Lewananczuk R et al. Overweight, physical activity and high blood pressure in children: a review of the literature. Vasc. Health Risk Manag.3, 139–149 (2007).
  • Berenson GS. Obesity: a critical issue in preventive cardiology – the Bogalusa Heart Study. Prev. Cardiol.8, 234–241 (2005).
  • Couch SC, Saelens BE, Levin L, Dart K, Falciglia G, Daniels SR. The efficacy of a clinic-based behavioural nutrition intervention emphasizing a DASH-type diet for adolescents with elevated blood pressure. J. Pediatr.152, 494–501 (2008).
  • Lichtenstein AH, Appel IJ, Brands M et al. Diet and lifestyle recommendations revision 2006: a scientific statement from the American hearth association nutrition committee. Circulation114, 82–96 (2006).
  • Invitti C, Gilardini L, Pontiggia B et al. Period prevalence ob abnormal glucose tolerance and cardiovascular risk factors among obese children attending an obesity centre in Italy. Nutr. Metab. Cardiovasc. Dis.16, 256–262 (2006).
  • Sanders PW. Dietary salt intake, salt sensitivity, and cardiovascular health. Hypertension53, 442–445 (2009).
  • Lagomarsino E, Saieh C, Aglony M. Up to Date in the diagnosis and treatment of high blood pressure in pediatrics. Recommendations from the Nephrology Branch of the Chilean Society of Pediatrics. Rev. Chil. Pediatr.79, 63–81 (2008).
  • Cook NR, Cutler JA, Obarzanek E et al.; Trial of Hypertension Prevention Collaborative Research Group. Long term effects of dietary sodium reduction on cardiovascular disease outcomes : observational follow-up of the trials of hypertension prevention (TOHP). Br. Med. J.334, 885–888 (2007).
  • Feng J. He, Naomi M. Marrero, and Graham A. MacGregor. Salt intake is related to soft drink consumption in children and adolescents: a link to obesity? Hypertension51, 629–634 (2008).
  • Liberman JN, Berger JE, Lewis M. Prevalence of antihypertensive, antidiabetic, and dyslipidemic prescription medication use among children and adolescents. Arch. Pediatr. Adolesc. Med.163, 357–364 (2009).
  • Flynn JT. Nifedipine in the treatment of hypertension in children. J. Pediatr.140, 787–788 (2002).
  • Flynn JT, Warnick SJ. Isradipine treatment of hypertension in children: a single-center experience. Pediatr. Nephrol.17, 748–753 (2002).
  • Silverstein DM, Champoux E, Aviles DH, Vehaskari VM. Treatment of primary and secondary hypertension in children. Pediatr. Nephrol.21, 820–827 (2006).
  • Wühl E, Mehls O, Schaefer F; ESCAPE Trial Group. Antihypertensive and antiproteinuric efficacy of ramipril in children with chronic renal failure. Kidney Int.66, 768–776 (2004).
  • Flynn JT, Daniels SR. Pharmacologic treatment of hypertension in children and adolescents. J. Pediatr.149, 746–754 (2006).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.